---
figid: PMC3461903__JCI61205.f2
figtitle: New molecular insights into peripheral T cell lymphomas
organisms:
- NA
pmcid: PMC3461903
filename: JCI61205.f2.jpg
figlink: /pmc/articles/PMC3461903/figure/F2/
number: F2
caption: Notably, different key points of PDGFR signaling can be the object of pharmacological
  inhibition. First, PDGFRs can be directly blocked by TKIs. Second, the immediate
  downstream JAK/STAT pathway, SRC kinase and PI3K can be selectively disrupted. Finally,
  in cases retaining NF-κB activity (around 30% of PTCL-NOSs), different molecules
  might be targeted. Adapted with permission from Expert Review of Hematology ().
papertitle: New molecular insights into peripheral T cell lymphomas.
reftext: Stefano A. Pileri, et al. J Clin Invest. 2012 Oct 1;122(10):3448-3455.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9421455
figid_alias: PMC3461903__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3461903__F2
ndex: 816fea75-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3461903__JCI61205.f2.html
  '@type': Dataset
  description: Notably, different key points of PDGFR signaling can be the object
    of pharmacological inhibition. First, PDGFRs can be directly blocked by TKIs.
    Second, the immediate downstream JAK/STAT pathway, SRC kinase and PI3K can be
    selectively disrupted. Finally, in cases retaining NF-κB activity (around 30%
    of PTCL-NOSs), different molecules might be targeted. Adapted with permission
    from Expert Review of Hematology ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFB
  - PDGFA
  - PDGFRB
  - BCR
  - IGKV3D-20
  - PDGFRA
  - CAT
  - CRAT
  - GLYAT
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TYK2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - SRC
  - JAK2
  - JAK1
  - EIF2AK2
  - AN
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - HRAS
  - MTG1
  - STAT3
  - STAT6
  - STAT1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - FOS
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - MYC
  - NFKB1
  - RELB
  - REL
  - NFKB2
  - phosphate
  - Cancer
---
